Clinical Trial For Experimental Ebola Treatment Halted In Liberia For Lack Of Patients

Agence France-Presse: Low infection rate halts Ebola treatment trials in Liberia
“Britain’s Wellcome Trust said that clinical trials it was funding for a new Ebola treatment in Liberia were halted on Tuesday due to a fall in new cases. … The Wellcome Trust said the decision was taken on Tuesday after the pharmaceutical company Chimerix, which manufactures the brincidofovir treatment, said it was withdrawing from the trial on Friday…” (2/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.